Jane Street
COLL icon

Jane Street’s Collegium Pharmaceutical COLL Stock Holding History

Jane Street’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,700
Closed -$206K – 9290
2023
Q4 		$206K Buy
+6,700
New +$168K ﹤0.01% 8175
2023
Q2 		– Sell
-26,500
Closed -$636K – 8773
2023
Q1 		$636K Buy
+26,500
New +$703K ﹤0.01% 5898

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Jane Street's COLL Position: Q1 2026 in Review

Jane Street sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 190,763 shares — an estimated $8.83M sold.

Jane Street first reported a position in COLL in Q3 2020 and held it in 14 quarters. The position peaked at $8.83M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Jane Street reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 190,763 Collegium Pharmaceutical shares in Q1 2026, an estimated $8.83M.
  • Jane Street first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 14 quarters.
  • Jane Street's Collegium Pharmaceutical position peaked at $8.83M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.